Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days for obtaining the report for the MLPA- BRCA1 & BRCA2 Deletion/Duplication Test is typically 14-21 days. This time frame allows for proper analysis of the test results and generation of the detailed report.

What are the prerequisites for the test MLPA- BRCA1 & BRCA2 Deletion/Duplication Test

  • Sample Type: Whole blood or extracted DNA
  • Sample Volume: 3-5 mL whole blood in EDTA tube or 10 µg DNA at a concentration of at least 50 ng/µL
  • Shipping: Samples must be shipped at room temperature
  • Requisition Form: A completed requisition form with all necessary patient information
  • Clinical Information: Relevant clinical information about the patient and their family history

What are the measure values for the test MLPA- BRCA1 & BRCA2 Deletion/Duplication Test

  • Deletion: Indicates the presence of a deletion in the BRCA1 or BRCA2 gene.
  • Duplication: Indicates the presence of a duplication in the BRCA1 or BRCA2 gene.
  • No Mutation Detected: Indicates that no deletion or duplication was detected in the BRCA1 or BRCA2 gene.

What does this test MLPA- BRCA1 & BRCA2 Deletion/Duplication Test identify?

This test, MLPA- BRCA1 & BRCA2 Deletion/Duplication Test, is used to identify deletions or duplications in the BRCA1 and BRCA2 genes. These genes are known to be associated with an increased risk of breast and ovarian cancer. By analyzing the DNA for these specific genetic changes, this test can help determine if an individual has an increased risk of developing these types of cancer.

Why is this test MLPA- BRCA1 & BRCA2 Deletion/Duplication Test taken?

The MLPA- BRCA1 & BRCA2 Deletion/Duplication Test is taken to identify any deletions or duplications in the BRCA1 and BRCA2 genes. Mutations in these genes are associated with an increased risk of breast and ovarian cancer. By detecting these genetic alterations, healthcare providers can assess an individual's risk of developing these types of cancer and recommend appropriate screening or preventive measures.

No FAQs available.

Customer Google Rating